
Buy ACTH 1-39 Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.

Buy ACTH 1-39 Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
ACTH 1-39 (CAS 9002-60-2), also known as Adrenocorticotropic Hormone or Corticotropin, is a synthetic 39-amino acid polypeptide with a molecular weight of 4541.14 g/mol. The full-length ACTH sequence is derived from the larger 241-amino acid precursor protein pro-opiomelanocortin (POMC) through post-translational proteolytic processing. ACTH contains the melanocortin pharmacophore sequence His-Phe-Arg-Trp (residues 6-9) shared across the melanocortin peptide family. Produced via solid-phase peptide synthesis, Corticotropin signals through the melanocortin-2 receptor (MC2R) and is the principal endogenous regulator of adrenal glucocorticoid secretion.
ACTH 1-39’s obligate requirement for the melanocortin receptor accessory protein (MRAP) to achieve functional MC2R signalling distinguishes it from other melanocortin peptides and has been the subject of detailed receptor pharmacology investigation. In vitro studies have shown that MRAP is a small single-transmembrane protein that interacts directly with MC2R, is required for receptor trafficking to the plasma membrane, and enables ACTH responsiveness, with MRAP loss-of-function mutations causing familial glucocorticoid deficiency type 2 [1]. Isogenic cell-system studies further established that human MRAP isoforms reconstitute ACTH-driven cAMP signalling at MC2R, confirming the MC2R/MRAP complex as the functional unit responding to ACTH [2]. ACTH also serves as the parent sequence for shorter melanocortin-derived peptides, including alpha-MSH (ACTH 1-13) and pharmacophore regions used in Semax/Selank-related analogues. In vivo, its defining whole-animal action is activation of the hypothalamic-pituitary-adrenal axis, with ACTH administration driving adrenal corticosterone responses in neonatal rats [3], making ACTH 1-39 an essential reference compound for structure-activity studies mapping ACTH-analogue binding and receptor-subtype selectivity across the MC1R-MC5R family.
ACTH 1-39 is manufactured in a cGMP compliant, ISO9001 certified laboratory to a guaranteed purity of 98% or above. Every batch is independently tested using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Editorial Team

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed and approved 14 June 2026
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Buy 5+ vials to unlock discounts
Quality Guaranteed
Every batch is HPLC-tested to ≥99% purity. Certificate of Analysis and MSDS available with every order.
